Eli Lilly (LLY) Interest Coverage Ratio (2009 - 2012)
Eli Lilly (LLY) reported Interest Coverage Ratio of 31.02 for Q1 2012, down 15.09% on a YoY basis from 36.53 in Q2 2011, and up 45.42% quarter-over-quarter from 21.33 in Q4 2011.
Eli Lilly (LLY) Interest Coverage Ratio (2009 - 2012) Analysis & Trends
Eli Lilly has reported Interest Coverage Ratio for 4 years, with the latest figure at 31.02 in Q1 2012.
- For the quarter ending Q1 2012, Interest Coverage Ratio fell 15.09% year-over-year to 31.02; the trailing twelve-month figure through Dec 2012 stood at 110.71 (up 248.05% YoY), and the FY2011 full-year result was 10.07, down 18.24% from the prior year.
- Interest Coverage Ratio for Q1 2012 stood at 31.02, up from 21.33 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 36.53 in Q1 2011, with the low at 21.33 in Q4 2011.
- Historically, Interest Coverage Ratio has averaged 31.74 across 4 years, with a median of 33.57 in 2010.
- Annual changes were most pronounced in 2010 — Interest Coverage Ratio soared 44.78% — and 2011, when it plunged 36.41%.
- Eli Lilly's Interest Coverage Ratio stood at 23.2 in 2009, then jumped by 44.57% to 33.54 in 2010, then sank by 36.41% to 21.33 in 2011, then surged by 45.42% to 31.02 in 2012.
- The last three Interest Coverage Ratio figures came in at 31.02 (Q1 2012), 21.33 (Q4 2011), and 35.24 (Q3 2011), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2012 | 31.02 |
| Dec 31, 2011 | 21.33 |
| Sep 30, 2011 | 35.24 |
| Jun 30, 2011 | 35.23 |
| Mar 31, 2011 | 36.53 |
| Dec 31, 2010 | 33.54 |
| Sep 30, 2010 | 32.31 |
| Jun 30, 2010 | 33.59 |
| Mar 31, 2010 | 35.36 |
| Jun 30, 2009 | 23.20 |